User:Ann Taylor/GLP-1 agonists: Difference between revisions
Jump to navigation
Jump to search
GLP-1 agonists
References
Ann Taylor (talk | contribs) New page: ==GLP-1 agonists== <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> Glucagon-like peptide agonists (GLP) are used to treat type 2 diabe... |
Ann Taylor (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==GLP-1 agonists== | ==GLP-1 agonists== | ||
<StructureSection load=' | <StructureSection load='GLP-1 peptide' size='340' side='right' caption='Caption for this structure' scene=''> | ||
Glucagon-like peptide agonists (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. | Glucagon-like peptide agonists (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. | ||
Revision as of 19:01, 25 April 2024
GLP-1 agonistsGLP-1 agonists
| |||||||||||
ReferencesReferences
- ↑ Drake T, Landsteiner A, Langsetmo L, MacDonald R, Anthony M, Kalinowski C, Ullman K, Billington CJ, Kaka A, Sultan S, Wilt TJ. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med. 2024 Apr 19. PMID:38639549 doi:10.7326/M23-1490